Blueblood Ventures Limited Files Revised Financial Results for H1 FY26
Blueblood Ventures Limited filed revised H1 FY26 results showing strong performance with ₹16.98 lakhs profit (vs ₹1.04 lakhs previous year) and ₹100.79 lakhs revenue (vs ₹32.08 lakhs). The revision corrected trade payables disclosure requirements. Auditors issued unmodified opinion but highlighted matters regarding ₹756.00 lakhs ZOCDs and ₹6,188.55 lakhs pending loan confirmations.
*this image is generated using AI for illustrative purposes only.
Blueblood Ventures Limited has submitted revised standalone financial results for the half year ended September 30, 2025, to BSE Limited on December 18, 2025. The revision was necessitated to correct the bifurcation of trade payables as required under accounting standards and Division I format, which was omitted in the original filing made on November 14, 2025.
Financial Performance Overview
The company demonstrated strong financial performance during the half year period, with significant improvements across key metrics compared to the previous year.
| Financial Metric | H1 FY26 (Sep 2025) | H1 FY25 (Sep 2024) | Change |
|---|---|---|---|
| Revenue from Operations | ₹100.79 lakhs | ₹32.08 lakhs | +214.14% |
| Other Income | ₹9.61 lakhs | ₹0.04 lakhs | +23,925% |
| Total Revenue | ₹110.40 lakhs | ₹32.12 lakhs | +243.70% |
| Net Profit | ₹16.98 lakhs | ₹1.04 lakhs | +1,532.69% |
| Basic & Diluted EPS | ₹0.57 | ₹0.03 | +1,800% |
The company's total expenses increased to ₹93.41 lakhs from ₹31.08 lakhs in the corresponding period, primarily due to higher other expenses of ₹90.25 lakhs compared to ₹5.21 lakhs in the previous year.
Balance Sheet Position
As of September 30, 2025, the company's financial position showed mixed developments across various categories.
| Balance Sheet Item | Sep 30, 2025 | Mar 31, 2025 | Change |
|---|---|---|---|
| Share Capital | ₹300.11 lakhs | ₹300.11 lakhs | No change |
| Reserves and Surplus | ₹13.45 lakhs | ₹(3.53) lakhs | Positive swing |
| Long-term Borrowings | ₹9,400.00 lakhs | ₹9,400.00 lakhs | No change |
| Total Assets/Liabilities | ₹10,053.42 lakhs | ₹10,024.14 lakhs | +0.29% |
Notably, the company's reserves and surplus turned positive at ₹13.45 lakhs from a negative ₹3.53 lakhs as of March 31, 2025, reflecting the improved profitability.
Auditor's Review and Key Matters
KRA & Associates, Chartered Accountants, issued an unmodified opinion on the financial results. However, they highlighted several matters of emphasis:
- Zero Optional Convertible Debentures: The company holds ₹756.00 lakhs in non-current investments (756 ZOCDs at ₹1 lakh each), with 509 in DEMAT account and 247 wrongly transferred to another party, which management is working to recover
- Long-term Loans and Advances: Pending confirmations worth ₹6,188.55 lakhs have been considered recoverable by management
- Service Tax Settlement: The company has applied under the Sabka Vishwas scheme for settlement of ₹27.04 lakhs in service tax matters related to FY 2017-18
Cash Flow Analysis
The company's cash flow statement revealed operational challenges despite improved profitability.
| Cash Flow Category | H1 FY26 | FY25 |
|---|---|---|
| Operating Activities | ₹(491.69) lakhs | ₹(320.73) lakhs |
| Investing Activities | ₹483.49 lakhs | ₹335.18 lakhs |
| Financing Activities | ₹0.00 lakhs | ₹(8.41) lakhs |
| Net Change in Cash | ₹(8.21) lakhs | ₹6.05 lakhs |
Cash and cash equivalents decreased to ₹1.27 lakhs from ₹9.48 lakhs as of March 31, 2025, primarily due to negative operating cash flows.
Corporate Governance
The Board of Directors, led by Managing Director Suresh Bohra, approved the financial results at their meeting held on November 14, 2025, which commenced at 14:00 PM and concluded at 16:30 PM. The Audit Committee reviewed and recommended the results before board approval, ensuring compliance with regulatory requirements under SEBI LODR Regulations 2015.
16
